Search research articles
Contact Us
Filters
Showing results (101-110 of 253) with videos related to
Page
of 26
Sort By:
International Immunology
|
August 9, 2008
Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model
Paula Borel, Mahdia Benkhoucha, Martin S Weber, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 2, 2020
Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS
Sarah Harris, Jonathan Q Tran, Harry Southworth, et al.
CNS Drugs
|
April 12, 2011
Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action
Patrice H Lalive, Oliver Neuhaus, Mahdia Benkhoucha, et al.
International Immunology
|
June 29, 1999
Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production
J M Soos, T A Ashley, J Morrow, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
June 5, 2025
Acknowledgment to Reviewers
Scott S Zamvil, Anne-Katrin Proebstel, Marinos C Dalakas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 29, 2004
Mitoxantrone as a potential therapy for primary progressive multiple sclerosis
Olaf Stüve, Mariko Kita, Daniel Pelletier, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 2, 1998
Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells
J M Soos, J Morrow, T A Ashley, et al.
The Journal of Experimental Medicine
|
December 1, 1985
Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition
S S Zamvil, P A Nelson, D J Mitchell, et al.
Genes and Immunity
|
February 22, 2002
Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA)
J C Patarroyo, O Stuve, J F Piskurich, et al.
Der Nervenarzt
|
September 28, 2004
[Statins for treatment of CNS diseases. Status report from research and clinical practice]
T Menge, H-C von Büdingen, S S Zamvil, et al.
Page
of 26
Search research articles
Search
Showing results (101-110 of 253) with videos related to
Sort By:
Page
of 26
International Immunology
|
August 9, 2008
Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model
Paula Borel, Mahdia Benkhoucha, Martin S Weber, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
August 2, 2020
Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS
Sarah Harris, Jonathan Q Tran, Harry Southworth, et al.
CNS Drugs
|
April 12, 2011
Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action
Patrice H Lalive, Oliver Neuhaus, Mahdia Benkhoucha, et al.
International Immunology
|
June 29, 1999
Differential expression of B7 co-stimulatory molecules by astrocytes correlates with T cell activation and cytokine production
J M Soos, T A Ashley, J Morrow, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
June 5, 2025
Acknowledgment to Reviewers
Scott S Zamvil, Anne-Katrin Proebstel, Marinos C Dalakas, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
June 29, 2004
Mitoxantrone as a potential therapy for primary progressive multiple sclerosis
Olaf Stüve, Mariko Kita, Daniel Pelletier, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 2, 1998
Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells
J M Soos, J Morrow, T A Ashley, et al.
The Journal of Experimental Medicine
|
December 1, 1985
Encephalitogenic T cell clones specific for myelin basic protein. An unusual bias in antigen recognition
S S Zamvil, P A Nelson, D J Mitchell, et al.
Genes and Immunity
|
February 22, 2002
Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA)
J C Patarroyo, O Stuve, J F Piskurich, et al.
Der Nervenarzt
|
September 28, 2004
[Statins for treatment of CNS diseases. Status report from research and clinical practice]
T Menge, H-C von Büdingen, S S Zamvil, et al.
Page
of 26